Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials.

Title: Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials.
Authors: Wallenstein GV; Kanik KS; Wilkinson B; Cohen S; Cutolo M; Fleischmann RM; Genovese MC; Gomez Reino J; Gruben D; Kremer J; Krishnaswami S; Lee EB; Pascual-Ramos V; Strand V; Zwillich SH.
Contributors: Wallenstein, Gv; Kanik, K; Wilkinson, B; Cohen, S; Cutolo, M; Fleischmann, Rm; Genovese, Mc; Gomez Reino, J; Gruben, D; Kremer, J; Krishnaswami, S; Lee, Eb; Pascual-Ramos, V; Strand, V; Zwillich, Sh.
Publication Year: 2016
Collection: Università degli Studi di Genova: CINECA IRIS
Description: Objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Here we investigated the effects of tofacitinib on patient-reported outcomes (PRO) in patients with active RA. Methods Two, 6-month, double-blind, placebo-controlled Phase 2b studies were performed. The combination study evaluated patients with inadequate response to methotrexate who received tofacitinib 1–15 mg twice daily (BID), 20 mg once daily or placebo, on background methotrexate. In the monotherapy study, patients with inadequate response to disease-modifying anti-rheumatic drugs received tofacitinib 1–15 mg BID, adalimumab 40 mg once every other week or placebo. PROs measured were: Patient’s Assessment of Arthritis Pain (PAAP), Patient’s Assessment of Disease Activity, HAQ-DI, FACIT-F and SF-36. Results In the combination study (n=507), significant improvements (p
Document Type: article in journal/newspaper
File Description: STAMPA
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/27156561; info:eu-repo/semantics/altIdentifier/wos/WOS:000376977900009; volume:34(3); firstpage:430; lastpage:442; numberofpages:13; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; https://hdl.handle.net/11567/969125
Availability: https://hdl.handle.net/11567/969125
Rights: info:eu-repo/semantics/closedAccess
Accession Number: edsbas.EE22647D
Database: BASE